“Our vision is clear, our goals are ambitious, and our determination is unyielding.” This was stated by Dr. Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers in his keynote address to the Indian Industry leaders in pharmaceuticals, and G20 Ministers and Delegates, on the sidelines of the G20 Health Minister’s Meeting in Gandhinagar. Dr. Mandaviya proudly acknowledged India’s prowess in the pharmaceuticals and medical devices field, emphasizing its role as a global hub for pharmaceutical excellence. “India is recognized as a cornerstone in the global pharmaceutical landscape,” he stated. The country’s dedication to providing affordable, high-quality drugs and its significant contribution to global accessibility were underscored, with India supplying around 60% of the world’s vaccine needs and 20-22% of generic exports. Dr. Mandaviya underscored India’s unwavering commitment to the well-being of humanity, particularly demonstrated during the COVID-19 pandemic. “In the battle against the pandemic, India supplied essential drugs to approximately 185 countries,” he proudly shared, emphasizing India’s role as a global leader. The keynote address focused on India’s vision for the future of healthcare, centered around a transition from volume-based approaches to a value-based leadership model. “Our commitment to quality, accessibility, and affordability in healthcare is unwavering,” he added. Under the visionary leadership of Prime Minister Narendra Modi, India’s government is resolute in driving meaningful change in the healthcare sector.
